Target intelligence / Profile preview

Mucopolysaccharide Synthesis

Molecular classification: Metabolic Pathway

Overview

Mucopolysaccharide synthesis refers to the biosynthetic processes that produce glycosaminoglycans (GAGs). These are long, unbranched polysaccharide chains composed of repeating disaccharide units, essential components of connective tissues, and play critical roles in cell adhesion, signaling, and structural integrity of extracellular matrices. Defects in GAG degradation, not synthesis, lead to mucopolysaccharidoses (MPS), lysosomal storage disorders characterized by undegraded GAG accumulation.

Other names: Glycosaminoglycan biosynthesisGAG biosynthesisAcid mucopolysaccharide synthesis

Biological functions

Production of long-chain polysaccharidesConnective tissue structureCell adhesionCell signalingExtracellular matrix integrity

Disease associations

Mucopolysaccharidoses (MPS)Lysosomal storage disorders

Beyond the preview

Go deeper on Mucopolysaccharide Synthesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucopolysaccharide Synthesis.

Explore the full profile